Abstract:This study reports the synthesis of the Schiff base ligand (Z)‐2‐(1‐((3‐methylpyridin‐2‐yl)imino)ethyl)phenol (HL), as well as its cobalt (II) and copper (II) metal complexes, designated M1L and M2L, respectively. The compounds were synthesized via a reversible condensation reaction between primary amines and carbonyl compounds. The Schiff base ligand and its metal complexes were characterized using multiple techniques, including thermogravimetric analysis, UV spectroscopy, 1HNMR spectroscopy, FTIR spectroscopy, and elemental analysis. The 1HNMR and FTIR spectral analysis indicate that the ligand exhibits iso‐bidentate behavior. The electronic spectra data reveal that charge transfer transitions are most prominent in the presence of the ligand, underscoring its crucial role in enhancing charge transfer processes. The zones of inhibition (mm) against gram‐positive and gram‐negative bacteria, including Enterococcus faecalis and Escherichia coli, were measured at least three times under identical conditions for both the Schiff base ligand and its metal complexes. Molecular docking modeling was utilized to ascertain the positioning of bonds, energy distribution, and molecular distances that influence the interactions among these complexes. The novel Schiff base, (Z)‐2‐(1‐((3‐methylpyridin‐2‐yl)imino)ethyl)phenol (HL), was synthesized by reacting 1‐(2‐hydroxyphenyl)ethanone with 3‐methylpyridin‐2‐amine. Metal complexes [M (L)n (H2O)2] (M = Co and Cu, n = 2) were synthesized and characterized utilizing various analytical techniques including UV–visible spectroscopy, FTIR, elemental analysis, molar conductance, 1H NMR, thermal analysis, and magnetic moment measurement. The findings indicated that the Co+2 and Cu+2 complexes exhibited octahedral geometries. In vitro biological activity testing was conducted to evaluate the antimicrobial potential of the complexes against Bacillus subtilis (B. subtilis) and Escherichia coli (E. coli) bacteria strains. Similarly, molecular docking was conducted to elucidate the interactions between the active sites of protein–metal complexes and dihydrofolate reductase as well as ferrochelatase.

Synthesis, characterization and antibacterial activity of a Schiff base derived from cephalexin and sulphathiazole and its transition metal complexes

Ceftriaxone-based Schiff base transition metal(II) complexes. Synthesis, characterization, bacterial toxicity, and DFT calculations. Enhanced antibacterial activity of a novel Zn(II) complex against S. aureus and E. coli

Synthesis, Characterization, DNA Cleavage, and Antimicrobial Studies of Some Transition Metal Complexes With a Novel Schiff Base Derived From 2-Aminopyrimidine

Synthesis, spectral studies and antimicrobial evaluation of transition metal complexes of bidentate Schiff base ligands derived from 4-amino quinoline

Synthesis, Characterization and in vitro Biological Evaluation of a New Schiff Base Derived from Drug and its Complexes with Transition Metal Ions

Syntheses, Crystal Structures and Antitumor Activity of Ni((II)/Zn(II) Complexes Containing Cephalexin Hydrolysate

Synthesis, structural elucidation, molecular modeling and antimicrobial studies of Mn(II), Co(II), Ni(II), and Cu(II) complexes containing NO donor bidentate Schiff base

Synthesis, structure elucidation, antioxidant, antimicrobial, anti-inflammatory and molecular docking studies of transition metal(II) complexes derived from heterocyclic Schiff base ligands

Synthesis and characterization of novel metal complexes with new azo-schiff base ligand derived from sulfa drug and toxicological studies of its complexes as antibacterial

Anion Induced Synthesis and Crystal Structures of Schiff Base Copper(II) and Zinc(II) Complexes with Antibacterial Activity

SYNTHESIS, CHARACTRIZATION AND ANTIBACTERIAL ACTIVITY OF SCHIFF BASES DERIVED FROM PHENYL HYDRAZINE DERIVATIVES AND THEIR Cu (II) and Zn (II) COMPLEXES

Synthesis, characterization and antimicrobial study of polymeric transition metal complexes of Mn(II), Co(II), Ni(II), Cu(II) and Zn(II)

Synthesis, Structural and Antimicrobial Studies of Transition Metal Complexes of a Novel Schiff Base Ligand Incorporating 1,2,4-Triazole and 4-(Benzyloxy)benzaldehyde Moieties

Synthesis, Characterization, and Antibacterial and Cytotoxic Study of Metal Complexes with Schiff Base Ligands

Synthesis, Characterization, Crystal Structure and Antimicrobial Activity of Copper(II) Complexes with the Schiff Base Derived from 2-Hydroxy-4-Methoxybenzaldehyde

Composition, Characterization and Antibacterial activity of Mn(II), Co(II),Ni(II), Cu(II) Zn(II) and Cd(II) mixed ligand complexes Schiff base derived from Trimethoprim with 8-Hydroxy quinoline

Synthesis and Spectral Studies of New Azomethine Metal Complexes With Biological Activity and Docking Studies Utilizing 3‐Methylpyridin‐2‐Amine as a Complexing Agent

Synthesis, spectro-themal characterization, DFT calculations and biochemical evaluation of a newly synthesized tridentate Schiff base transition metal complexes

Synthesis, spectroscopic characterization, density functional theory calculations and biological evaluation of novel Cu(II) and Zn(II) Schiff base complexes as antimicrobial agents

Synthesis, Characterization and Biological Activity of Transition Metals Schiff Base Complexes Derived from 4,6-Diacetylresorcinol and 1,8-Naphthalenediamine

Coordination Modes of a Schiff Base Derived from Substituted 2-Aminothiazole with Chromium(III), Manganese(II), Iron(II), Cobalt(II), Nickel(II) and Copper(II) Metal Ions: Synthesis, Spectroscopic and Antimicrobial Studies